We found that the lung cancer group exhibited higher PD-1+ NK cell levels than the healthy donors (5.62% ± 4.49% vs. 2.08% ± 0.38%, p = 0.0037; Fig. 2A and 2B). This evidence concerns the gene PDCD1 and lung cancer.